Anixa Biosciences, Inc. (ANIX)
4.79
-0.34
(-6.63%)
USD |
NASDAQ |
Dec 11, 12:28
Anixa Biosciences Shareholders Equity (Quarterly): 16.60M for July 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Puma Biotechnology, Inc. | 115.27M |
| GT Biopharma, Inc. | 3.00M |
| ImmunityBio, Inc. | -524.32M |
| Lexeo Therapeutics, Inc. | 120.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.65M |
| Total Liabilities (Quarterly) | 2.24M |
| Debt to Equity Ratio | 0.0128 |
| Current Ratio | 8.446 |
| Net Debt Paydown Yield | -0.01% |